Cancer drug brigimadlin tested for Long-Term safety in ongoing patients
NCT ID NCT06619509
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 24 times
Summary
This study looks at the long-term safety of the cancer drug brigimadlin in adults with solid tumors who have already taken it for at least 4 cycles in a previous study. Participants take brigimadlin tablets once every 3 weeks at the study site. Doctors monitor their health, track side effects, and check tumor size. The goal is to see how well people tolerate long-term treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Arthur J. E. Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2, Canada
-
CTR Eugène Marquis
Rennes, 35042, France
-
CTR Leon Berard
Lyon, 69373, France
-
Clinexpert Gyongyos
Gyöngyös, 3200, Hungary
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
-
Copenhagen University Hospital, Rigshospitalet
København Ø, 2100, Denmark
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, 20133, Italy
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Fundación Jiménez Díaz
Madrid, 28040, Spain
-
Helios Klinikum Berlin-Buch
Berlin, 13125, Germany
-
Henry-Joyce Cancer Clinic
Nashville, Tennessee, 37232, United States
-
Hospital Clínico de Santiago
Santiago de Compostela, 15706, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario HM Sanchinarro
Madrid, 28050, Spain
-
Hospital Universitario Miguel Servet
Aragon, 50009, Spain
-
Istituto Oncologico Veneto IRCCS
Padova, 35128, Italy
-
Kanagawa Cancer Center
Kanagawa, Yokohama, 241-8515, Japan
-
Karolinska Comprehensive Cancer Center
Stockholm, SE-171 76, Sweden
-
Kyushu University Hospital
Fukuoka, Fukuoka, 812-8582, Japan
-
Mayo Clinic Cancer Center
Jacksonville, Florida, 32224, United States
-
National Cancer Center Hospital
Tokyo, Chuo-ku, 104-0045, Japan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, Fukuoka, 811-1395, Japan
-
Nebraska Cancer Specialists-Omaha-69066
Omaha, Nebraska, 68130, United States
-
Northwell Health
Lake Success, New York, 11042, United States
-
Okayama University Hospital
Okayama, Okayama, 700-8558, Japan
-
Oncology Center-Maria Sklodowska-Curie Institute
Warsaw, 02-781, Poland
-
Osaka International Cancer Institute
Osaka, Osaka, 541-8567, Japan
-
Oslo Universitetssykehus HF, Radiumhospitalet
Oslo, N-0379, Norway
-
Precision NextGen Oncology
Beverly Hills, California, 90212, United States
-
Prince of Wales Hospital-Randwick-66496
Randwick, New South Wales, 2031, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
Sanatorio Finochietto
CABA, C1120AAB, Argentina
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
Sourasky Medical Center
Tel Aviv, 6423906, Israel
-
Sun Yat-Sen University Cancer Center
Guangzhou, 510060, China
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
-
The Royal Marsden Hospital, London
London, SW3 6JJ, United Kingdom
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Tohoku University Hospital
Miyagi, Sendai, 980-8574, Japan
-
UZ Leuven
Leuven, 3000, Belgium
-
University College Hospital
London, NW12PQ, United Kingdom
-
University Hospital Olomouc
Olomouc, 77900, Czechia
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
-
Utah Cancer Specialists Cancer Center
Salt Lake City, Utah, 84106, United States
-
Washington University School of Medicine
St Louis, Missouri, 63108, United States
-
West Cancer Center & Research Institute
Germantown, Tennessee, 38138, United States
-
Yale Cancer Center
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.